NL8101899A - Farmaceutisch preparaat voor orale toediening met daarin cytidinedifosfocholine. - Google Patents

Farmaceutisch preparaat voor orale toediening met daarin cytidinedifosfocholine. Download PDF

Info

Publication number
NL8101899A
NL8101899A NL8101899A NL8101899A NL8101899A NL 8101899 A NL8101899 A NL 8101899A NL 8101899 A NL8101899 A NL 8101899A NL 8101899 A NL8101899 A NL 8101899A NL 8101899 A NL8101899 A NL 8101899A
Authority
NL
Netherlands
Prior art keywords
choline
cdp
pharmaceutical preparation
oral administration
phospholipids
Prior art date
Application number
NL8101899A
Other languages
English (en)
Dutch (nl)
Original Assignee
Made Italiana Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana Srl filed Critical Made Italiana Srl
Publication of NL8101899A publication Critical patent/NL8101899A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8101899A 1980-04-18 1981-04-16 Farmaceutisch preparaat voor orale toediening met daarin cytidinedifosfocholine. NL8101899A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale
IT4845480 1980-04-18

Publications (1)

Publication Number Publication Date
NL8101899A true NL8101899A (nl) 1981-11-16

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8101899A NL8101899A (nl) 1980-04-18 1981-04-16 Farmaceutisch preparaat voor orale toediening met daarin cytidinedifosfocholine.

Country Status (15)

Country Link
US (1) US4386077A (Sortimente)
AT (1) AT376366B (Sortimente)
AU (1) AU544469B2 (Sortimente)
BE (1) BE890796A (Sortimente)
CH (1) CH652026A5 (Sortimente)
DE (1) DE3115080C2 (Sortimente)
DK (1) DK173081A (Sortimente)
ES (1) ES502080A0 (Sortimente)
FR (1) FR2480603B1 (Sortimente)
GB (1) GB2074445B (Sortimente)
IN (1) IN156105B (Sortimente)
IT (1) IT1207106B (Sortimente)
NL (1) NL8101899A (Sortimente)
SE (1) SE447449B (Sortimente)
ZA (1) ZA812600B (Sortimente)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (en) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. New pharmaceutical composition
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5482706A (en) * 1992-04-17 1996-01-09 Takeda Chemical Industries, Ltd. Transmucosal therapeutic composition
AU5304796A (en) * 1995-03-06 1996-09-23 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
US8030294B2 (en) * 2000-03-16 2011-10-04 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
JPWO2004075905A1 (ja) * 2003-02-26 2006-06-01 協和醗酵工業株式会社 筋肉増強剤および筋肉減衰の予防または治療剤
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
EP1765364A4 (en) * 2004-06-10 2010-09-22 Mclean Hospital Corp PYRIMIDINES, SUCH AS Z: B: CYTIDINE, IN THE TREATMENT OF PATIENTS WITH BIPOLAR DISORDER
WO2006020703A1 (en) * 2004-08-11 2006-02-23 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1189549A (en) * 1967-12-18 1970-04-29 Takeda Chemical Industries Ltd A Method for Production of Cytidine (Deoxycytidine)-5'-Diphosphate Choline and Intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (Sortimente) * 1969-08-04 1973-12-07
JPS4886869A (Sortimente) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
IT1207106B (it) 1989-05-17
SE447449B (sv) 1986-11-17
US4386077A (en) 1983-05-31
AT376366B (de) 1984-11-12
ES8207184A1 (es) 1982-09-01
AU6994581A (en) 1981-10-22
SE8102456L (sv) 1981-10-19
ZA812600B (en) 1982-04-28
DE3115080C2 (de) 1986-10-16
CH652026A5 (it) 1985-10-31
BE890796A (fr) 1982-02-15
IN156105B (Sortimente) 1985-05-18
FR2480603B1 (fr) 1985-07-12
GB2074445B (en) 1983-09-07
IT8048454A0 (it) 1980-04-18
DE3115080A1 (de) 1982-02-25
GB2074445A (en) 1981-11-04
FR2480603A1 (fr) 1981-10-23
DK173081A (da) 1981-10-19
ATA172081A (de) 1984-04-15
ES502080A0 (es) 1982-09-01
AU544469B2 (en) 1985-05-30

Similar Documents

Publication Publication Date Title
NL8101899A (nl) Farmaceutisch preparaat voor orale toediening met daarin cytidinedifosfocholine.
US5929066A (en) Chromium/biotin treatment of Type II diabetes
JP3699124B2 (ja) タイプｉｉ糖尿病のピコリン酸クロム高用量治療
JP2002249427A (ja) インスリン抵抗性糖尿病のための食事用補添物
AU751431B2 (en) Chromium/biotin treatment of type II diabetes
GB2103485A (en) Liposomes containing antimony anti-leishmanaisis drugs
CN106617072A (zh) 一种植物甾醇复合降脂组方及其片剂制备方法
MC1575A1 (fr) Nouveau derives de la guanine
CN1329497A (zh) 对乙型肝炎病毒的联合治疗
O'Connell et al. Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
WO2005084660A1 (ja) ミトコンドリア病予防と対策
OA11655A (en) Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants.
AU651824B2 (en) Pharmaceutical composition
US5240700A (en) Pharmaceutical composition comprising a medicament and 3-oxygermylpropionic acid
US7122209B2 (en) Oral compositions for the treatment of non-diabetic obese mammals, including humans
JP2753936B2 (ja) ▲ｉ▼型及び▲ｉｉ▼型糖尿病改善剤の製造方法
JPH08165236A (ja) 下痢の予防及び治療剤
EP0435693B1 (en) Pharmaceutical compositions containing 3-oxygermylpropionic acid polymers for inhibiting the degeneration of cells
JP2004522775A (ja) 抗癌薬
EP0082667A1 (en) Pharmaceutical compositions
SU876135A1 (ru) Гипохолестеринемическое средство "билигнин
AU2002302012B2 (en) Chromim/biotin treatment of type II diabetes
WO2023109825A1 (zh) 氧化银和/或其水合物在制备药物中的用途
JPS632414B2 (Sortimente)
WO1996011679A1 (en) Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed